Lucrecia Yáñez Selected Research

Lucrecia Yáñez Research Topics

7	Neoplasms (Cancer) 03/2024 - 04/2015
6	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 12/2019 - 10/2017
5	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 11/2023 - 01/2021
4	Infections 01/2023 - 12/2021
2	Sepsis (Septicemia) 03/2024 - 01/2022
2	B-Cell Lymphoma (Lymphoma, B Cell) 01/2023 - 04/2019
2	Pneumonia (Pneumonitis) 09/2022 - 03/2022
2	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2021 - 04/2019
2	Thrombocytopenia (Thrombopenia) 06/2019 - 01/2019
1	Septic Shock (Toxic Shock Syndrome) 03/2024
1	Cross Infection (Nosocomial Infection) 01/2023
1	Hematologic Neoplasms (Hematological Malignancy) 01/2023
1	Bacteremia 01/2023
1	Diarrhea 01/2023
1	Mucositis 09/2022
1	Febrile Neutropenia 01/2022
1	Fusariosis 01/2021
1	Lung Diseases (Lung Disease) 01/2021
1	Rheumatoid Arthritis 01/2021
1	Neutropenia 01/2021
1	Disease Progression 06/2019
1	Lymphopenia (Lymphocytopenia) 06/2019
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 04/2019
1	Chromosomal Instability (Chromosome Stability) 01/2019
1	Breast Neoplasms (Breast Cancer) 01/2019
1	Fanconi Anemia (Fanconi's Anemia) 01/2019
1	Second Primary Neoplasms (Neoplasms, Second) 10/2017
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2017
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2017
1	Carcinogenesis 04/2015
1	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 09/2014
1	Venous Thrombosis (Deep-Vein Thrombosis) 09/2005
1	Protein S Deficiency (Deficiency, Protein S) 09/2005

4	Anti-Bacterial Agents (Antibiotics)IBA 03/2024 - 03/2022
4	Rituximab (Mabthera)FDA Link 01/2021 - 10/2017
2	UbiquitinIBA 12/2021 - 01/2021
1	Carbapenems (Carbapenem Antibiotics)IBA 03/2024
1	Chimeric Antigen ReceptorsIBA 01/2023
1	Cefepime (Maxipime)FDA LinkGeneric 01/2022
1	Tazobactam Drug Combination Piperacillin (Zosyn)FDA LinkGeneric 01/2022
1	Meropenem (Merrem)FDA LinkGeneric 01/2022
1	LactamsIBA 01/2022
1	ibrutinibIBA 12/2021
1	tisagenlecleucelIBA 04/2019
1	axicabtagene ciloleucelIBA 04/2019
1	tetrachloroisophthalonitrile (Bravo)IBA 01/2019
1	Thrombopoietin ReceptorsIBA 01/2019
1	Fanconi Anemia Complementation Group ProteinsIBA 01/2019
1	Biomarkers (Surrogate Marker)IBA 12/2017
1	Dihydrotachysterol (AT 10)IBA 10/2017
1	Cytostatic AgentsIBA 01/2017
1	fludarabineIBA 01/2017
1	Protein Isoforms (Isoforms)IBA 04/2015
1	DNA (Deoxyribonucleic Acid)IBA 04/2015
1	thymoglobulin FDA Link 09/2014
1	Factor XII (Hageman Factor)IBA 09/2005

8	Stem Cell Transplantation 01/2021 - 01/2017
7	Therapeutics 03/2024 - 04/2019
7	Hematopoietic Stem Cell Transplantation 01/2023 - 09/2014
3	Transplantation 01/2017 - 09/2014
2	Secondary Prevention 12/2019 - 12/2018
1	Artificial Respiration (Mechanical Ventilation) 03/2024
1	Cell Transplantation 01/2023
1	Catheters 09/2022
1	Central Venous Catheters 12/2021
1	Organ Transplantation 01/2021
1	Immunotherapy 12/2019
1	Drug Therapy (Chemotherapy) 10/2017